EFFECTS OF GRADED DOSES OF VASOPRESSIN ON MEDIAN FIBRILLATION FREQUENCY IN A PORCINE MODEL OF CARDIOPULMONARY-RESUSCITATION - RESULTS OF A PROSPECTIVE, RANDOMIZED, CONTROLLED TRIAL
Hu. Strohmenger et al., EFFECTS OF GRADED DOSES OF VASOPRESSIN ON MEDIAN FIBRILLATION FREQUENCY IN A PORCINE MODEL OF CARDIOPULMONARY-RESUSCITATION - RESULTS OF A PROSPECTIVE, RANDOMIZED, CONTROLLED TRIAL, Critical care medicine, 24(8), 1996, pp. 1360-1365
Objective: To assess the effects of graded doses of vasopressin vs. sa
line on median fibrillation frequency a nd defibrillation success in a
porcine model of cardiopulmonary resuscitation. Design: Prospective,
randomized, controlled trial. Setting: Animal laboratory in a universi
ty medical center. Subjects: Twenty-eight domestic pigs (body weight b
etween 26 and 31 kg), aged 12 to 14 wks. Interventions and Main Result
s: After 4 mins of ventricular fibrillation and 3 mins of closed-chest
cardiopulmonary resuscitation, the animals were allocated to receive
either 0.2 U/kg of vasopressin (n = 7), 0.4 U/kg of vasopressin (n = 7
), 0.8 U/kg of vasopressin (n = 7), or 10 mL of saline (n = 7, control
group). Using radiolabeled microspheres, myocardial blood flow rates
during cardiopulmonary resuscitation-before drug administration and 90
secs and 5 mins after drug administration-were as follows in the four
groups (mean +/- SEM): 18.8 +/- 0.9, 17.2 +/- 1.1, and 14.6 +/- 1.4 m
L/min/100 g in the control group; 17.8 +/- 2.2, 49.6 +/- 6.3 (p <.01 v
s. control group), and 29.4 +/- 3.1 mL/min/100 g (p <.05 vs. central g
roup) in the group receiving 0.2 U/kg of vasopressin; 17.1 +/- 1.0, 52
.4 +/- 7.5 (p <.01 vs, control group), and 52.2 +/- 5.8 mL/min/100 g (
p <.001 vs, control group) in the group receiving 0.4 U/kg of vasopres
sin; and 18.1 +/- 1.6, 94.9 +/- 9.2 (p <.001 vs. control group), and 5
7.2 +/- 6.3 mL/min/100 g (p <.001 vs. control group) in the group rece
iving 0.8 U/kg of vasopressin. Using spectral analysis, median frequen
cies of ventricular fibrillation-before drug administration and 90 sec
s and 5 mins after drug administration-were as follows in the four gro
ups: 9.6 +/- 0.4, 8.5 +/- 0.8, and 7.2 +/- 1.0 Hz in the control group
; 9.7 +/- 0.5, 12.9 +/- 0.8 (p <.01 vs. control group), and 12.7 +/- 0
.8 Hz (p <.001 vs. control group) in the group receiving 0.2 U/kg of v
asopressin; 10.3 +/- 0.2, 12.7 +/- 0.9 (p <.01 vs. control group), and
12.8 +/- 0.7 Hz (p <.001 vs. control group) in the group receiving 0.
4 U/kg of vasopressin; and 10.0 +/- 0.9, 14.1 +/- 0.9 (p < .001 vs, co
ntrol group), and 12.5 +/- 0.9 Hz (p <.001 vs. control group) in the g
roup receiving 0.8 U/kg of vasopressin at the same points in time. Med
ian frequency before the first defibrillation attempt was 12.3 +/- 0.4
Hz in the resuscitated animals (n = 19) and 8.2 +/- 1.2 Hz in the non
resuscitated animals (n = 9) (p <.001).Conclusions: This study contrib
utes to the characterization of the effect of increasing global myocar
dial blood flow on median fibrillation frequency after administration
of graded doses of vasopressin in a porcine model of ventricular fibri
llation. Interventions such as vasopressor treatment that increase fib
rillation frequency improve the chance of successful defibrillation.